Drug Approval | March 02, 2024
Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg
The product will be launched in March 2024
The product will be launched in March 2024
Eugia Pharma Specialities restarts production at terminally sterilized product lines
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The observations do not pose any risk to site's compliance standards or its business continuity
We are achieving the target of developed India by making our young children healthy today
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government
Subscribe To Our Newsletter & Stay Updated
